Scientific Sessions 2025  /  Novel Insights into Cardio-oncology  /  Cyp1a treatment for anthracycline cardiomyopathy
Logo

American Heart Association

  47
  0

Final ID:

Cyp1a treatment for anthracycline cardiomyopathy

  • Asnani, Aarti  ( Beth Israel Deaconess , Arliton , Massachusetts , United States )
    • Author Disclosures:
    Aarti Asnani: DO have relevant financial relationships ; Royalties/Patent Beneficiary:UpToDate:Active (exists now) ; Research Funding (PI or named investigator):Genentech:Active (exists now) ; Ownership Interest:Corventum, Inc.:Active (exists now) ; Royalties/Patent Beneficiary:Mass General Brigham:Active (exists now)
Meeting Info:

Scientific Sessions 2025

2025

New Orleans, Louisiana

Session Info:

Novel Insights into Cardio-oncology

Monday, 11/10/2025 , 09:45AM - 11:00AM

Cardiovascular Seminar

More abstracts on this topic:
Intersection between cancer and cardiovascular diseases

Leeper Nick

Cario-oncology in the vascular system

Abe Junichi

More abstracts from these authors:
How To Build a Research Career in Cardio-Oncology

Asnani Aarti

Biomarkers for Cardiotoxicity Monitoring: Do We Really Need Them, Or Are They Just Extra Baggage? (Con)

Nohria Anju, Asnani Aarti

You have to be authorized to contact abstract author. Please, Login
Not Available